ARCHIVES

FDA Approves Tamoxifen For “Reduction In Incidence,” Avoids Word “Prevention”

This article is from The Cancer Letter archive.

Vol. 24 No. 42 | November 6, 1998

Download PDF Visit The Full Archive

Related Articles

FDA Authority To Regulate Off-Label Promotion Challenged In Federal Court.

January 15, 2010

Senate Appropriations Committee Slashes NCI Funds By $25 Million

August 18, 1978

NCI Selects 15 Awardees to Operate the Cancer Information Service.

January 7, 2005

In Brief: AMOS Says Cancer Program Should Not Have Ceiling Of $1 Billion; OSHA Drops Effort To Fire Infants

August 14, 1981

High-Dose Vitamin D With Docetaxel In Testing For Advanced Prostate Cancer

September 27, 2002

Sausville to lead clinical research at Maryland.

December 5, 2003